Effects of Acetaminophen consumption in asthmatic children

S Oshnouei1, Sh Salarilak, A Khalkhali

  • 1MSc student of Epidemiology, Epidemiology and Biostatistics Department, Faculty of Medicine, Urmia Medical University, Iran.

Insights

Acetaminophen use in children aged 2-8 years is linked to an increased risk of asthma. Further research is needed to establish clear guidelines for its use, especially for fever management.

Area of Science:

  • Pediatrics
  • Epidemiology
  • Public Health

Background:

  • Acetaminophen (paracetamol) use has been anecdotally linked to rising asthma rates.
  • The association between acetaminophen exposure and childhood asthma requires further investigation.

Purpose of the Study:

  • To investigate the association between acetaminophen exposure and the risk of developing childhood asthma.

Main Methods:

  • A case-control study was conducted in Urmia, Iran, involving 207 asthmatic children (cases) and 414 non-asthmatic children (controls) aged 2-8 years.
  • Cases and controls were matched for age and gender.
  • Parental questionnaires collected data on acetaminophen exposure.

Main Results:

  • Acetaminophen use in the first year of life showed no significant association with asthma risk (p=0.19).
  • However, acetaminophen exposure in children aged 2-8 years was significantly associated with an increased risk of asthma (p<0.001).
  • A dose-response relationship was observed, with higher frequency of acetaminophen use correlating with greater asthma risk (ORs ranging from 3.8 to 4.2).

Conclusions:

  • Acetaminophen consumption increases the risk of asthma in children aged 2-8 years.
  • More robust evidence is needed to inform guidelines on reducing acetaminophen use for fever and post-vaccination management.
Abstract

Related Concept Videos

Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Antiasthma Drugs: Methylxanthines01:24

Antiasthma Drugs: Methylxanthines

Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...